Keren Medical

Company Overview

Snapshot

Founded in October 2007 by Dan Sadeh Hochstadter and Ofer Yossepiwitch, Keren Medical operates with 1–10 employees. The company has raised $600,000 across one funding round from VLX Ventures. Keren Medical ceased operations in September 2021.

Business overview

Keren Medical develops a surgical instrument designed to automate and simplify anastomosis between the bladder and urethra following radical prostatectomy. Their core technology is a disposable device, AutoTy, which rapidly installs and fixates absorbable sutures, eliminating the need for complex manual suturing, particularly in robotic surgery. This innovation aims to improve safety, speed, and precision in urological procedures, serving hospitals and surgeons within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.

Company Intelligence Q&A

What is Keren Medical's primary product?

Keren Medical's primary product is AutoTy, a disposable surgical device designed for automatic suturing during prostate anastomosis following radical prostatectomy.

When was Keren Medical founded?

Keren Medical was founded in October 2007.

Who are the founders of Keren Medical?

Keren Medical was founded by Dan Sadeh Hochstadter and Ofer Yossepiwitch.

What is the status of Keren Medical?

Keren Medical is currently non-active and ceased to operate in September 2021.

What was Keren Medical's last disclosed funding round?

Keren Medical secured Seed funding of $600,000 in January 2012 from VLX Ventures.